Tsai CM - Search Results

1

Safety and efficacy of first-line bevacizumab with chemotherapy in Asian patients with advanced nonsquamous NSCLC: results from the phase IV MO19390 (SAiL) study.

Tsai CM, Au JS, Chang GC, Cheng AC, Zhou C, Wu YL. Tsai CM, et al. J Thorac Oncol. 2011 Jun;6(6):1092-7. doi: 10.1097/JTO.0b013e318216687d. J Thorac Oncol. 2011. PMID: 21512405 Free article. Clinical Trial.

2

[Small cell lung cancer and long-term survival: our experience in VGH-Taipei from 1971 to 1985].

Chen YM, Tsai CM, Perng RP. Chen YM, et al. Among authors: tsai cm. Zhonghua Yi Xue Za Zhi (Taipei). 1992 Apr;49(4):271-6. Zhonghua Yi Xue Za Zhi (Taipei). 1992. PMID: 1318152 Chinese.

3

Schedule-dependent in vitro combination effects of methotrexate and 5-fluorouracil in human tumor cell lines.

Tsai CM, Gazdar AF, Perng RP, Kramer BS. Tsai CM, et al. Int J Cancer. 1991 Feb 1;47(3):401-7. doi: 10.1002/ijc.2910470316. Int J Cancer. 1991. PMID: 1847123

4

Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.

Tsai CM, Hsiao SH, Frey CM, Chang KT, Perng RP, Gazdar AF, Kramer BS. Tsai CM, et al. Cancer Res. 1993 Mar 1;53(5):1079-84. Cancer Res. 1993. PMID: 8382553

5

Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.

Chen YM, Wu MF, Perng RP, Chou CM, Yang KY, Lin WC, Tsai CM, Liu JM, Whang-Peng J. Chen YM, et al. Among authors: tsai cm. Jpn J Clin Oncol. 1997 Apr;27(2):76-9. doi: 10.1093/jjco/27.2.76. Jpn J Clin Oncol. 1997. PMID: 9152794 Clinical Trial.

6

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

Perng RP, Chen YM, Ming-Liu J, Tsai CM, Lin WC, Yang KY, Whang-Peng J. Perng RP, et al. Among authors: tsai cm. J Clin Oncol. 1997 May;15(5):2097-102. doi: 10.1200/JCO.1997.15.5.2097. J Clin Oncol. 1997. PMID: 9164223 Clinical Trial.

7

Ifosfamide-based chemotherapy for previously treated lung cancer patients.

Chen YM, Liu JM, Wu MF, Wu HW, Lin WC, Tsai CM, Perng RP, Whang-Peng J. Chen YM, et al. Among authors: tsai cm. Zhonghua Yi Xue Za Zhi (Taipei). 1998 Jul;61(7):389-96. Zhonghua Yi Xue Za Zhi (Taipei). 1998. PMID: 9699391 Clinical Trial.

8

Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.

Lai CL, Tsai CM, Tsai TT, Kuo BI, Chang KT, Fu HT, Perng RP, Chen JY. Lai CL, et al. Among authors: tsai cm, tsai tt. Clin Cancer Res. 1998 Dec;4(12):3025-30. Clin Cancer Res. 1998. PMID: 9865916

9

A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.

Chen YM, Perng RP, Yang KY, Lin WC, Wu HW, Liu JM, Tsai CM, Whang-Peng J. Chen YM, et al. Among authors: tsai cm. Am J Clin Oncol. 2000 Feb;23(1):13-7. doi: 10.1097/00000421-200002000-00003. Am J Clin Oncol. 2000. PMID: 10683066 Clinical Trial.

10

A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer.

Perng RP, Shih JF, Chen YM, Delgado FM, Tsai CM, Chou KC, Liu JM, Chern MS, Whang-Peng J. Perng RP, et al. Among authors: tsai cm. Am J Clin Oncol. 2000 Feb;23(1):60-4. doi: 10.1097/00000421-200002000-00017. Am J Clin Oncol. 2000. PMID: 10683080 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

453 results

Search Page

Filters